Insys Therapeutics, Inc. (INSYQ) financial statements (2022 and earlier)

Company profile

Business Address 10220 SOUTH 51ST STREET
PHOENIX, AZ 85044
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:104,100117,188182,880159,09182,86345,382
Cash and cash equivalents31,55231,999104,64279,51558,10645,382
Short-term investments64,12685,18978,23879,57624,757 
Other undisclosed cash, cash equivalents, and short-term investments8,422     
Receivables12,61021,51320,65448,45926,54416,313
Inventory, net of allowances, customer advances and progress billings8,60817,40821,74341,71534,78114,528
Inventory8,60817,40821,74341,71534,78114,528
Deferred tax assets    4,6113,800
Other undisclosed current assets97419,8335,6953,9732,2432,127
Total current assets:126,292175,942230,972253,238151,04282,150
Noncurrent Assets
Inventory, Noncurrent    (3,318) 
Property, plant and equipment52,08655,17443,17238,38229,87210,127
Long-term investments and receivables8,44646,73353,79643,21923,262 
Long-term investments8,44646,73353,79643,21923,262 
Other noncurrent assets5,7031,2314,953263,34343
Deferred tax assets, net  23,243 7,6028,238
Other undisclosed noncurrent assets   16,3313,318 
Total noncurrent assets:66,235103,138125,16497,95864,07918,408
TOTAL ASSETS:192,527279,080356,136351,196215,121100,558
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:50,85930,43827,35936,35427,45416,557
Employee-related liabilities6,4378,8088,83310,2256,9263,568
Other undisclosed accounts payable and accrued liabilities44,42221,63018,52626,12920,52812,989
Estimated litigation liability41,402150,53413,4679,567  
Customer refund liability8,16216,29028,95532,71311,296 
Deferred revenue and credits1,109    
Other undisclosed current liabilities6,4378,8088,83310,2256,9264,524
Total current liabilities:106,860207,17978,61488,85945,67621,081
Noncurrent Liabilities
Liabilities, other than long-term debt128,7678,6197,9338,6353,778 
Liability for uncertainty in income taxes3,7678,6197,9338,6353,778 
Estimated litigation liability125,000     
Total noncurrent liabilities:128,7678,6197,9338,6353,778 
Total liabilities:235,627215,79886,54797,49449,45421,081
Stockholders' equity
Stockholders' equity attributable to parent, including:(43,100)63,282269,589253,702165,66779,477
Common stock7447367197193545
Treasury stock, value(32,558)(32,558)(32,558)   
Additional paid in capital292,508278,356256,529245,736216,414168,526
Accumulated other comprehensive loss(269)(438)(302)(152)(24) 
Retained earnings (accumulated deficit)(336,083)(215,351)12,6647,420(51,056)(89,033)
Stockholders' equity note, subscriptions receivable (21) 
Other undisclosed stockholders' equity attributable to parent32,55832,55832,537(21)(21)(21)
Total stockholders' equity:(43,100)63,282269,589253,702165,66779,477
TOTAL LIABILITIES AND EQUITY:192,527279,080356,136351,196215,121100,558

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues82,080140,693242,275330,797222,12599,289
Revenue, net140,693242,275330,797222,12599,289
Cost of revenue(10,803)(20,643)(25,393)(28,854)(22,578)(12,665)
Cost of goods and services sold(3,095)(6,186)    
Gross profit:71,277120,050216,882301,943199,54786,624
Operating expenses(199,000)(339,081)(209,556)(209,513)(135,524)(54,065)
Operating income (loss):(127,723)(219,031)7,32692,43064,02332,559
Nonoperating income (expense)1,3161,8361,098538153(982)
Investment income, nonoperating1,9841,8811,039502151 
Other nonoperating income (expense)(668)(45)59362(54)
Interest and debt expense     (900)
Other undisclosed income from continuing operations before equity method investments, income taxes     900
Income (loss) from continuing operations before income taxes:(126,407)(217,195)8,42492,96864,17631,577
Income tax expense (benefit)1,900(10,820)(834)(34,492)(26,199)8,800
Net income (loss) available to common stockholders, diluted:(124,507)(228,015)7,59058,47637,97740,377

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(124,507)(228,015)7,59058,47637,97740,377
Comprehensive income (loss):(124,507)(228,015)7,59058,47637,97740,377
Other undisclosed comprehensive income (loss), net of tax, attributable to parent169(136)(150)(128)(24) 
Comprehensive income (loss), net of tax, attributable to parent:(124,338)(228,151)7,44058,34837,95340,377

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: